Nillni E A, Sevarino K A, Jackson I M
Department of Medicine, Brown University, Rhode Island Hospital, Providence 02903.
Endocrinology. 1993 Mar;132(3):1271-7. doi: 10.1210/endo.132.3.8440188.
The intracellular compartments where posttranslational processing of proTRH takes place have not been identified. Using AtT20 cells transfected with a complementary DNA for preproTRH, we have used purified antibodies that recognize the intact precursor, intermediate and end products of processing to identify the subcellular compartments in which cleavage occur. Further, pulse-chase experiments followed by subcellular fractionation were undertaken to determine the order of processing of proTRH during its transport to the secretory granules. Cells were homogenized by nitrogen cavitation and subjected to a centrifugation of 1.065 mg/ml density gradient of Percoll to separate secretory granules (SG) from rough endoplasmic reticulum (RER)/Golgi apparatus. The purity of the SG and RER fractions was assessed by assays of marker enzymes for mitochondria, RER, Golgi, and cytoplasm. ProTRH derived cryptic peptides and TRH in each fraction were determined by RIA. Golgi and SG fractions were subjected to polyacrylamide gel electrophoresis followed by extraction and RIA. Using the anti-pCC10 antiserum which recognizes intact (26 kd) as well as partially processed prohormone, the RER/Golgi fraction contained 0.3 pmol intact ProTRH and 0.2 pmol each 15 and 6 kilodalton (kDa) fragments; the SG contained the 15 kDa moiety (0.2 pmol) along with a 6 kDa (0.4 pmol) material but not the 26 kDa ProTRH. The SG were also enriched by 0.21 pmol pYE27 (PreproTRH 25-50), 0.23 pmol pFT (PreproTRH 53-74), 0.31 pmol pEH24 (PreProTRH 86-106), and 0.5 pmol TRH. None of these were present in the RER/Golgi. Pulse-chase studies also showed that the intact proTRH (26 kDa) precursor was only present in the RER/Gg fraction along with two of its N-terminal intermediate processing products, a 15 k mol wt peptide and a 6 k mol wt peptide, and two of its C-terminal processing products, a 16.5 k mol wt and a 9.6 k mol wt peptides. In addition, fully processed peptides as well as TRH were only detected in the neurosecretory granules. These observations suggest that after the initial conversion of proTRH in the RER/Golgi fraction, the peptides are delivered to the granules where processing to TRH and cryptic peptides takes place. Supporting this, our pulse-chase studies unequivocally showed that, pEH24, an end product of proTRH processing, was only produced in secretory granules. Thus, initial cleavage of the TRH precursor may be required for packing and sorting of the end products to occur.
促甲状腺激素释放激素原(proTRH)进行翻译后加工的细胞内区室尚未明确。利用转染了促甲状腺激素释放激素原前体互补DNA的AtT20细胞,我们使用了能识别完整前体、中间产物和加工终产物的纯化抗体,以鉴定发生切割的亚细胞区室。此外,进行了脉冲追踪实验,随后进行亚细胞分级分离,以确定proTRH在转运至分泌颗粒过程中的加工顺序。通过氮气空化使细胞匀浆,并在1.065mg/ml的Percoll密度梯度中进行离心,以将分泌颗粒(SG)与粗面内质网(RER)/高尔基体分离。通过对线粒体、RER、高尔基体和细胞质的标记酶进行测定,评估SG和RER组分的纯度。通过放射免疫分析(RIA)测定各组分中proTRH衍生的隐蔽肽和促甲状腺激素释放激素(TRH)。对高尔基体和SG组分进行聚丙烯酰胺凝胶电泳,随后进行提取和RIA。使用能识别完整(26kd)以及部分加工的激素原的抗pCC10抗血清,RER/高尔基体组分含有0.3pmol完整的ProTRH以及0.2pmol的15kDa和6kDa片段;SG含有15kDa部分(0.2pmol)以及6kDa物质(0.4pmol),但不含有26kDa的ProTRH。SG还富含0.21pmol的pYE27(促甲状腺激素释放激素原前体25 - 50)、0.23pmol的pFT(促甲状腺激素释放激素原前体53 - 74)、0.31pmol的pEH24(促甲状腺激素释放激素原前体86 - 106)和0.5pmol的TRH。这些物质在RER/高尔基体中均不存在。脉冲追踪研究还表明,完整的proTRH(26kDa)前体仅与它的两个N端中间加工产物(一个15kDa分子量的肽和一个6kDa分子量的肽)以及它的两个C端加工产物(一个16.5kDa分子量和一个9.6kDa分子量的肽)一起存在于RER/高尔基体组分中。此外,仅在神经分泌颗粒中检测到完全加工的肽以及TRH。这些观察结果表明,在RER/高尔基体组分中proTRH发生初始转化后,这些肽被输送到颗粒中,在那里加工成TRH和隐蔽肽。支持这一观点的是,我们的脉冲追踪研究明确表明,proTRH加工的终产物pEH24仅在分泌颗粒中产生。因此,TRH前体的初始切割可能是终产物进行包装和分选所必需的。